人类冠状病毒在神经退行性疾病中的神经毒性影响:从粉样蛋白聚合的角度来看
Thi Hong Van Nguyen1, Francois Ferron2,3, Kazuma Murakami1
1Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.
ACS chemical biology
|April 24, 2025
概括
人类冠状病毒 (HCoV) 感染与神经退行性疾病有关. 这项研究探讨了HCoV.
科学领域:
- 神经科学是一个神经科学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 人类冠状病毒 (HCoV) 主要导致呼吸系统疾病.
- 新出现的证据表明,HCoV感染与神经功能障碍之间存在联系.
- 在神经系统疾病中区分直接病毒影响与先前存在的疾病是具有挑战性的.
研究的目的:
- 调查HCoV感染与特定的神经退行性疾病之间的关联.
- 分析HCoV感染的长期神经系统后果.
- 通过将病毒蛋白与宿主蛋白进行比较,探索潜在的神经病变机制.
主要方法:
- 审查关于HCoV感染和神经结果的现有文献.
- 对HCoV尖端蛋白和amyloidogenic蛋白之间的序列和结构相似性的比较分析.
- 检查有关HCoV对神经退行性疾病流行率的影响的流行病学数据.
主要成果:
- 人类冠状病毒感染与神经退行性疾病的风险增加和进展有关.
- 长期的神经效应因年龄和性别而异.
- 在HCoV尖端蛋白和amyloidogenic蛋白之间发现的结构相似性表明神经退行症的潜在机制.
结论:
- 人类冠状病毒可能在神经退行性疾病的发病过程中直接或间接地发挥作用.
- 需要进一步的研究来阐明精确的机制,并制定有针对性的干预措施.
- 了解这些联系对于管理急性感染和长期神经健康至关重要.
相关概念视频
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Alzheimer's Disease: Overview
358
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
358
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360


